Mark Halvorson

Array ( [id] => 3815270 [patent_doc_number] => 05710247 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-20 [patent_title] => 'Process and intermediates for the synthesis of LHRH antagonists' [patent_app_type] => 1 [patent_app_number] => 8/618674 [patent_app_country] => US [patent_app_date] => 1996-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23370 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/710/05710247.pdf [firstpage_image] =>[orig_patent_app_number] => 618674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3815256 [patent_doc_number] => 05710246 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-20 [patent_title] => 'Process for intermediates for the synthesis of LHRH antagonists' [patent_app_type] => 1 [patent_app_number] => 8/618547 [patent_app_country] => US [patent_app_date] => 1996-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23543 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/710/05710246.pdf [firstpage_image] =>[orig_patent_app_number] => 618547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3740466 [patent_doc_number] => 05753629 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Distamycin A analogues as antitumour or antiviral agents' [patent_app_type] => 1 [patent_app_number] => 8/612836 [patent_app_country] => US [patent_app_date] => 1996-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17359 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 238 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753629.pdf [firstpage_image] =>[orig_patent_app_number] => 612836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1056468 [patent_doc_number] => 06855691 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-15 [patent_title] => 'Methods for producing and using S-nitrosohemoglobins' [patent_app_type] => utility [patent_app_number] => 08/616371 [patent_app_country] => US [patent_app_date] => 1996-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 19 [patent_no_of_words] => 11316 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/855/06855691.pdf [firstpage_image] =>[orig_patent_app_number] => 08616371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4027980 [patent_doc_number] => 05902790 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-11 [patent_title] => 'Pharmaceutical angiostatic dipeptide compositions and method of use thereof' [patent_app_type] => 1 [patent_app_number] => 8/614764 [patent_app_country] => US [patent_app_date] => 1996-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8311 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/902/05902790.pdf [firstpage_image] =>[orig_patent_app_number] => 614764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4047655 [patent_doc_number] => 05869450 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'Anti-inflammatory compositions and method with corticotropin-releasing factor analogs' [patent_app_type] => 1 [patent_app_number] => 8/611537 [patent_app_country] => US [patent_app_date] => 1996-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 6296 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869450.pdf [firstpage_image] =>[orig_patent_app_number] => 611537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3789551 [patent_doc_number] => 05840838 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Process for enhancing the activity of amyloid .beta. peptides' [patent_app_type] => 1 [patent_app_number] => 8/609090 [patent_app_country] => US [patent_app_date] => 1996-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 4590 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840838.pdf [firstpage_image] =>[orig_patent_app_number] => 609090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3769894 [patent_doc_number] => 05849691 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Peptidomimetic inhibitors of cathepsin D and plasmepsins I and II' [patent_app_type] => 1 [patent_app_number] => 8/603737 [patent_app_country] => US [patent_app_date] => 1996-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11609 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849691.pdf [firstpage_image] =>[orig_patent_app_number] => 603737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3988870 [patent_doc_number] => 05919444 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Method for decreasing severity of acute and chronic pancreatitis' [patent_app_type] => 1 [patent_app_number] => 8/603784 [patent_app_country] => US [patent_app_date] => 1996-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 8125 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919444.pdf [firstpage_image] =>[orig_patent_app_number] => 603784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3628333 [patent_doc_number] => 05686423 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Di-and tri-peptide mimetic compounds for Parkinson\'s disease' [patent_app_type] => 1 [patent_app_number] => 8/602361 [patent_app_country] => US [patent_app_date] => 1996-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 5790 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686423.pdf [firstpage_image] =>[orig_patent_app_number] => 602361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4051639 [patent_doc_number] => 05932538 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Nitrosated and nitrosylated .alpha.-adrenergic receptor antagonist compounds, compositions and their uses' [patent_app_type] => 1 [patent_app_number] => 8/595732 [patent_app_country] => US [patent_app_date] => 1996-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12959 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 815 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932538.pdf [firstpage_image] =>[orig_patent_app_number] => 595732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3773965 [patent_doc_number] => 05849954 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Method of peptide synthesis' [patent_app_type] => 1 [patent_app_number] => 8/588187 [patent_app_country] => US [patent_app_date] => 1996-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10902 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849954.pdf [firstpage_image] =>[orig_patent_app_number] => 588187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3727961 [patent_doc_number] => 05703050 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-30 [patent_title] => 'Urea derivatives, their preparation and use' [patent_app_type] => 1 [patent_app_number] => 8/513815 [patent_app_country] => US [patent_app_date] => 1996-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11884 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 432 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/703/05703050.pdf [firstpage_image] =>[orig_patent_app_number] => 513815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4064104 [patent_doc_number] => 05866545 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Substituted ketone derivatives as inhibitors of interleukin-1.beta. converting enzyme' [patent_app_type] => 1 [patent_app_number] => 8/578613 [patent_app_country] => US [patent_app_date] => 1996-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8312 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866545.pdf [firstpage_image] =>[orig_patent_app_number] => 578613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3874123 [patent_doc_number] => 05824652 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-20 [patent_title] => 'Heterocyclic acyldipeptides, processes for the preparation thereof and pharmaceutical compositions containing the same' [patent_app_type] => 1 [patent_app_number] => 8/537782 [patent_app_country] => US [patent_app_date] => 1996-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17953 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/824/05824652.pdf [firstpage_image] =>[orig_patent_app_number] => 537782 [rel_patent_id] =>[rel_patent_doc_number] =>)